Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MiMedx Group, Inc.(MDXG) | 28,195,249 | 28,195,249 | 0 | $217.10M | $195.39M | 63.71% | -$21.71M |
| Bioventus Inc.CL A(BVS) | 13,021,324 | 13,021,324 | 0 | $67.71M | $74.87M | 24.41% | +$7.16M |
| TELA Bio, Inc.(TELA) | 4,110,709 | 4,110,709 | 0 | $23.31M | $19.32M | 6.30% | -$3.99M |
| EyePoint, Inc.(EYPT) | 1,551,521 | 1,551,521 | 0 | $32.07M | $13.50M | 4.40% | -$18.57M |
| MediciNova, Inc.(MNOV) | 1,105,941 | 1,105,941 | 0 | $1.60M | $1.59M | 0.52% | -$11.1K |
| Revance Therapeutics Inc | 457,085 | 457,085 | 0 | $2.25M | $1.17M | 0.38% | -$1.07M |
| Venus Concept, Inc. | 1,089,190 | 1,089,190 | 0 | $752.6K | $852.8K | 0.28% | +$100.2K |